pdufa
saveMerck & Co Inc — (doravirine + islatravir hydrate) (PDUFA)
community read0 votes
Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)
Data sources
globaldata
Found something off?
same company · ±60 days · 4
- earningsMerck & Co., Inc. earningsApr 30, 2026
- phase 1 initiationMK-6050: Merck & Co Inc — MK-6050 (Phase I Trial Initiation)Apr 30, 2026
- phase 2 completionpembrolizumab: Merck & Co Inc — pembrolizumab (Phase II Trial Completion)Apr 30, 2026
- phase 2 completiontulisokibart: Merck & Co Inc — tulisokibart (Phase II Trial Completion)Apr 30, 2026
related news · 4
- biopharma diveMerck ADC, licensed from China, hits mark in first big global trial
- oncliveCapivasertib/Fulvestrant Yields Numerical OS Advantage in PIK3CA/AKT1/PTEN–Altered Breast Cancer
- biopharma diveMerck still sees ‘compelling’ outlook for Terns leukemia drug
- biopharma diveMerck adds to pharma’s AI push; Roche details MS drug results
comments(0)
5-min edit window · permanent after that